Skip to main navigation

News & Events Publications Patient Resources Contact
  • About Us
    • Leadership
    • Board
    • Scientific Advisors
    • Careers & Culture
    • Open Opportunities
  • Science
    • HBV Assets
      • Imdusiran (AB-729)
      • AB-101
  • Pipeline
  • Partnering
  • >
  • Investors
    • Investor Center
    • Stock Information
    • Financial Information
    • Corporate Governance
    • Press Releases
    • Events & Presentations
    • Investor FAQ
    • Contact Us
  • Culture & Careers

Investor Relations

  • Investor Center
  • Stock Information
  • Financial Information
  • Corporate Governance
  • Press Releases
  • Events & Presentations
  • Investor FAQ
  • Contact Us

Press Releases

Mar 23, 2026
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
PDF Version
Mar 03, 2026
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
PDF Version

Shareholder Tools

  • Email Alerts Email Alerts
  • RSS News Feeds RSS News Feeds
  • Download Library Download Library

© 2026 Arbutus Biopharma

Legal Terms